van Wezel T - Search Results

1

Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance.

Nooij LS, Ter Haar NT, Ruano D, Rakislova N, van Wezel T, Smit VTHBM, Trimbos BJBMZ, Ordi J, van Poelgeest MIE, Bosse T. Nooij LS, et al. Among authors: van poelgeest mie, van wezel t. Clin Cancer Res. 2017 Nov 15;23(22):6781-6789. doi: 10.1158/1078-0432.CCR-17-1302. Epub 2017 Sep 12. Clin Cancer Res. 2017. PMID: 28899974

2

Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.

Lombaerts M, Middeldorp JW, van der Weide E, Philippo K, van Wezel T, Smit VT, Cornelisse CJ, Cleton-Jansen AM. Lombaerts M, et al. Among authors: van der weide e, van wezel t. Biochem Biophys Res Commun. 2004 Jun 25;319(2):697-704. doi: 10.1016/j.bbrc.2004.05.041. Biochem Biophys Res Commun. 2004. PMID: 15178462

3

Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.

van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, van Wezel T, Hes FJ, Morreau H. van Puijenbroek M, et al. Among authors: van wezel t. Clin Cancer Res. 2008 Jan 1;14(1):139-42. doi: 10.1158/1078-0432.CCR-07-1705. Clin Cancer Res. 2008. PMID: 18172263

4

Progression and tumor heterogeneity analysis in early rectal cancer.

Lips EH, van Eijk R, de Graaf EJ, Doornebosch PG, de Miranda NF, Oosting J, Karsten T, Eilers PH, Tollenaar RA, van Wezel T, Morreau H. Lips EH, et al. Among authors: van eijk r, van wezel t. Clin Cancer Res. 2008 Feb 1;14(3):772-81. doi: 10.1158/1078-0432.CCR-07-2052. Clin Cancer Res. 2008. PMID: 18245538

5

Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.

Corver WE, Middeldorp A, ter Haar NT, Jordanova ES, van Puijenbroek M, van Eijk R, Cornelisse CJ, Fleuren GJ, Morreau H, Oosting J, van Wezel T. Corver WE, et al. Among authors: van puijenbroek m, van eijk r, van wezel t. Cancer Res. 2008 Dec 15;68(24):10333-40. doi: 10.1158/0008-5472.CAN-08-2665. Cancer Res. 2008. PMID: 19074902

6

Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.

Middeldorp A, Jagmohan-Changur S, van Eijk R, Tops C, Devilee P, Vasen HF, Hes FJ, Houlston R, Tomlinson I, Houwing-Duistermaat JJ, Wijnen JT, Morreau H, van Wezel T. Middeldorp A, et al. Among authors: van eijk r, van wezel t. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3062-7. doi: 10.1158/1055-9965.EPI-09-0601. Epub 2009 Oct 20. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19843678

7

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

van Eijk R, Licht J, Schrumpf M, Talebian Yazdi M, Ruano D, Forte GI, Nederlof PM, Veselic M, Rabe KF, Annema JT, Smit V, Morreau H, van Wezel T. van Eijk R, et al. Among authors: van wezel t. PLoS One. 2011 Mar 8;6(3):e17791. doi: 10.1371/journal.pone.0017791. PLoS One. 2011. PMID: 21408138 Free PMC article.

8

Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases.

de Miranda NF, Goudkade D, Jordanova ES, Tops CM, Hes FJ, Vasen HF, van Wezel T, Morreau H. de Miranda NF, et al. Among authors: van wezel t. Clin Cancer Res. 2012 Mar 1;18(5):1237-45. doi: 10.1158/1078-0432.CCR-11-1997. Epub 2012 Jan 18. Clin Cancer Res. 2012. PMID: 22261803

9

Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Corver WE, Ruano D, Weijers K, den Hartog WC, van Nieuwenhuizen MP, de Miranda N, van Eijk R, Middeldorp A, Jordanova ES, Oosting J, Kapiteijn E, Hovens G, Smit J, van Wezel T, Morreau H. Corver WE, et al. Among authors: van nieuwenhuizen mp, van eijk r, van wezel t. PLoS One. 2012;7(6):e38287. doi: 10.1371/journal.pone.0038287. Epub 2012 Jun 1. PLoS One. 2012. PMID: 22675538 Free PMC article.

10

Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.

Sarasqueta AF, Forte G, Corver WE, de Miranda NF, Ruano D, van Eijk R, Oosting J, Tollenaar RA, van Wezel T, Morreau H. Sarasqueta AF, et al. Among authors: van eijk r, van wezel t. BMC Cancer. 2013 Jun 5;13:277. doi: 10.1186/1471-2407-13-277. BMC Cancer. 2013. PMID: 23739040 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page